Shingrix® Shingles Vaccine for Adults 50+ and Immunocompromised Individuals
USAMP#60557144SKU: 58160082311
License Required
Product Spotlight
- SHINGRIX is a recombinant, adjuvanted vaccine formulated to prevent herpes zoster (shingles) in adults aged 50 years and older, offering significant protection against this painful condition.
- Not suitable for the prevention of primary varicella (chickenpox) infection, SHINGRIX is specifically designed to combat shingles.
- Additionally, SHINGRIX is recommended for adults aged 18 years and older who are at increased risk of shingles due to immunodeficiency or immunosuppression from disease or therapy.
- Each SHINGRIX dose is supplied as two components that must be mixed before administration, delivered in a single-dose vial of 0.5 mL for injection.
